https://www.fxempire.com/stocks/espr/history
Esperion Therapeutics, Inc. (ESPR) Stock Price History | FXEmpire
Get in-depth historical insights into (ESPR) Esperion Therapeutics, Inc.'s stock performance. With data on prices, highs, lows, and change percentages, our...
stock price historyesperion therapeuticsincespr
https://www.ig.com/it-ch/azioni/mercati-azioni/esperion-therapeutics-inc
Trading Azioni Esperion Therapeutics Inc | Prezzo Azioni Esperion Therapeutics Inc | IG Svizzera |...
Esperion Therapeutics, Inc. is a commercial stage biopharmaceutical company. The Company is focused on developing and commercializing oral,... [IT-CH]
esperion therapeuticstradingazioniincprezzo
https://www.macrotrends.net/stocks/charts/ESPR/esperion-therapeutics/dividend-yield-history
Esperion Therapeutics - 55 Year Dividend History | ESPR | MacroTrends
Historical dividend payout and yield for Esperion Therapeutics (ESPR) since 1971. The current TTM dividend payout for Esperion Therapeutics (ESPR) as of May...
esperion therapeuticsdividend history55yearespr
https://www.prnewswire.com/news-releases/critical-alerts-for-juno-therapeutics-inc-broadcom-eli-lilly-esperion-therapeutics-and-world-wrestling-entertainment-released-by-investorsobserver-300089825.html
Critical Alerts For Juno Therapeutics Inc, Broadcom, Eli Lilly, Esperion Therapeutics and World...
/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JUNO, BRCM, LLY, ESPR and WWE. To see what our analysts have discovered about a...
juno therapeutics
https://menafn.com/1111059540/HAREHOLDER-ALERT-The-MA-Class-Action-Firm-Announces-An-Investigation-Of-Esperion-Therapeutics-Inc-NASDAQ-ESPR
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation Of Esperion Therapeutics,...
https://www.foxbusiness.com/markets/esperion-therapeutics-climbs-as-company-says-high-cholesterol-drug-met-goals-in-trial
Esperion Therapeutics climbs as company says high cholesterol drug met goals in trial | Fox Business
Shares of Esperion Therapeutics surged in aftermarket trading Wednesday after the company reported positive clinical trial results for its experimental...